Public-health officials make plans for how to speed up responses to tropical-disease outbreaks.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
Scientific Reports Open Access 05 February 2016
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
08 June 2015
The original version of this story did not explicitly state that the US Food and Drug Administration was not consulted about or involved in the design of the Oxford University brincidofovir study; it has advocated generally for the conduct of randomized clinical trials to study drugs against Ebola virus disease. The text has been updated to reflect this.
Related links
Related links
Related links in Nature Research
Liberia is declared Ebola free 2015-May-09
Share the risks of Ebola vaccine development 2015-Mar-18
Data sharing: Make outbreak research open access 2015-Feb-25
Related external links
World Health Organization on Ebola
Rights and permissions
About this article
Cite this article
Check Hayden, E. Ebola teaches tough lessons about rapid research. Nature 521, 405â406 (2015). https://doi.org/10.1038/521405a
Published:
Issue date:
DOI: https://doi.org/10.1038/521405a
This article is cited by
-
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
Scientific Reports (2016)
-
« Back to the Future ». Les essais vaccinaux contre Ebola, au regard de lâhistoire des résistances à lâimmunisation
Bulletin de la Société de pathologie exotique (2016)